Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-19T12:22:02.207Z Has data issue: false hasContentIssue false

46213 Florida Community-Engaged Research Alliance Against COVID-19 in Disproportionately Affected Communities (FL-CEAL): addressing education, awareness, access, and inclusion of underserved communities in COVID-19 research

Published online by Cambridge University Press:  30 March 2021

Olveen Carrasquillo
Affiliation:
University of Miami
Erin Kobetz-Kerman
Affiliation:
University of Miami
Victoria Behar-Zusman
Affiliation:
University of Miami
Sheela Dominguez
Affiliation:
University of Miami
Mario DeLa Rosa
Affiliation:
Florida International University
Elena Bastida
Affiliation:
Florida International University
Eric Wagner
Affiliation:
Florida International University
Adrianna Campa
Affiliation:
Florida International University
Folakemi Odedina
Affiliation:
University of Florida
Elizabeth Shenkman
Affiliation:
University of Florida
Cynthia Harris
Affiliation:
Florida A&M University
Katherine Chung-Bridges
Affiliation:
Health Choice Network
Timothy Long
Affiliation:
Health Choice Network
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

ABSTRACT IMPACT: Understanding the needs and barriers or facilitators to participation in research, especially among minority communities is critical not only for COVID-19 research but also for future clinical and translational research and health disparities studies. OBJECTIVES/GOALS: The overall goal of this project is to enhance education, awareness, access, and inclusion of underserved communities across Florida in COVID-19 research, especially among Black and Hispanic minority groups that are disproportionately affected by COVID-19. METHODS/STUDY POPULATION: Through strategic partnership among five academic institutions and community-based organizations across the state of Florida, the FL-CEAL team will implement focus groups and surveys in minority communities in Florida to gauge the awareness and understanding of COVID-19, and the barriers and facilitators for participation in COVID-19 research studies. These communities include but are not limited to Latinx and Black populations in South and Central Florida, and Black communities in North Florida. The outcomes will help shape strategies for outreach and dissemination activities and minority recruitment plans to promote participation of minorities into vaccine and therapeutic trials. RESULTS/ANTICIPATED RESULTS: An estimated 75-125 participants will be recruited for focus groups. Four focus groups with minority communities have been conducted and the results are being analyzed. A common Community-Based Needs Assessment survey is being finalized and will be deployed across the 11 states that are part of the national CEAL consortium. Community Health Workers are being engaged to support outreach and dissemination to educate targeted communities on COVID-19 research and the importance of participation in COVID trials. To date, 243 CHWs and 880 community members have been engaged. Minority participation in COVID-19 vaccine trials at University of Miami has been higher than the national average. DISCUSSION/SIGNIFICANCE OF FINDINGS: The FL-CEAL Alliance has successfully demonstrated a coordinated effort to engage minority communities affected by COVID. Through strategic geographic partnerships, FL-CEAL will positively impact minority communities throughout the state that has one of the most diverse populations in the nation.

Type
Health Equity & Community Engagement
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Association for Clinical and Translational Science 2021